Synthesis of pyrimidine hybrids reveals anti-proliferative effects and EGFR TK inhibition, suggesting potential therapies.
Two pyrimidine hybrid series (6a–g, 10a–d) were synthesized. Compounds 6c and 10b showed anti-proliferative activity against MCF-7, strong EGFR-TK inhibition, and docking confirmed effective binding. In silico studies suggest safe, orally bioavailable candidates.
No takes yet. Share an insight, caveat, or question.
Shehta et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: